Inflammatory Bowel Disease

Discussing the latest advances in Crohn’s disease and ulcerative colitis

Items Tagged ‘The Lancet’

June 5, 2014

Etrolizumab and IBD

By Margaret Shepard, Communications Specialist Margaret_Marie

Edward Loftus Jr., M. D., discusses a recently published article in The Lancet about the phase two trial of Etrolizumab, which is a drug for patients with moderate to severe ulcerative colitis.   The molecule of this drug is an antibody directed at a substance called beta seven integrin. Integrins are molecules that act with […]

View full entry

Tags: Edward Loftus, Etrolizumab, FDA, IBD, The Lancet, ulcerative colitis


Contact Us · Privacy Policy